Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer

被引:4
作者
Guckenberger, M. [1 ]
Saur, G. [1 ]
Wehner, D. [1 ]
Sweeney, R. A. [1 ]
Thalheimer, A. [2 ]
Germer, C. -T. [2 ]
Flentje, M. [1 ]
机构
[1] Univ Klinikum Wurzburg, Klin & Poliklin Strahlentherapie, D-97080 Wurzburg, Germany
[2] Univ Klinikum Wurzburg, Chirurg Klin 1, D-97080 Wurzburg, Germany
关键词
Rectal neoplasms; Prognosis; Radiotherapy; 5-Fluorouracil; Oxaliplatin; POSTOPERATIVE CHEMORADIOTHERAPY; ELDERLY-PATIENTS; FOLLOW-UP; INVOLVEMENT; MULTICENTER; SURVIVAL; TRIAL;
D O I
10.1007/s00066-012-0131-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this work was to perform a single institution comparison between preoperative short-course radiotherapy (SC-RT) and long-course radiochemotherapy (LC-RCHT) for locally advanced rectal cancer. A total of 225 patients with clinical stage UICC II-III rectal cancer were treated with SC-RT (29 Gy in 10 twice daily fractions followed by immediate surgery; n = 108) or LC-RCHT (54 Gy in 28 fractions with simultaneous 5-fluorouracil (5-FU) +/- oxaliplatin chemotherapy followed by delayed surgery; n = 117). All patients in the LC-RCHT cohort and patients in the SC-RT with pathological UICC stage a parts per thousand yenaEuro parts per thousand II received adjuvant chemotherapy. Before 2004, the standard of care was SC-RT with LC-RCHT reserved for patients where downstaging was considered as required for sphincter preservation or curative resection. In the later period, SC-RT was practiced only for patients unfit for radiochemotherapy. Patients in the LC-RCHT cohort had a significantly higher proportion of cT4 tumors, clinical node positivity, and lower tumor location. The 5-year local control (LC) and overall survival (OS) were 91% and 66% without differences between the SC-RT and LC-RCHT groups. Acute toxicity was increased during LC-RCHT (grade a parts per thousand yenaEuro parts per thousand II 1% vs. 33%) and there were no differences in postoperative complications. Severe late toxicity grade a parts per thousand yenaEuro parts per thousand III was increased after SC-RT (12% vs. 3%). Of patients aged > 80 years, 7 of 7 patients and 4 of 9 patients received curative surgery after SC-RT and LC-RCHT, respectively. Despite the fact that patients with worse prognostic factors were treated with LC-RCHT, there were no significant differences in LC and OS between the SC-RT and LC-RCHT group. Age > 80 years was identified as a significant risk factor for LC-RCHT and these patients could be treated preferably with SC-RT.
引用
收藏
页码:551 / 557
页数:7
相关论文
共 50 条
  • [31] Short-Course versus Long-Course Chemoradiation in Rectal Cancer—Time to Change Strategies?
    Manisha Palta
    Christopher G. Willett
    Brian G. Czito
    Current Treatment Options in Oncology, 2014, 15 : 421 - 428
  • [32] Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: A systematic review and meta-analysis
    Zhou, Zhi-Rui
    Liu, Shi-Xin
    Zhang, Tian-Song
    Chen, Ling-Xiao
    Xia, Jun
    Hu, Zhi-De
    Li, Bo
    SURGICAL ONCOLOGY-OXFORD, 2014, 23 (04): : 211 - 221
  • [33] Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer
    Chin, Re-, I
    Otegbeye, Ebunoluwa E.
    Kang, Kylie H.
    Chang, Su-Hsin
    McHenry, Scott
    Roy, Amit
    Chapman, William C., Jr.
    Henke, Lauren E.
    Badiyan, Shahed N.
    Pedersen, Katrina
    Tan, Benjamin R.
    Glasgow, Sean C.
    Mutch, Matthew G.
    Samson, Pamela P.
    Kim, Hyun
    JAMA NETWORK OPEN, 2022, 5 (02)
  • [34] Neoadjuvant Short- Vs. Long-Course Radiation for Locally Advanced Rectal Cancer: How to Choose
    Willett, Christopher G.
    Acklin-Wehnert, Scarlett
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (04) : 427 - 433
  • [35] Short-course radiotherapy in stage IV rectal cancer with resectable disease
    Cambray, M.
    Gonzalez-Viguera, J.
    Macia, M.
    Losa, F.
    Soler, G.
    Frago, R.
    Mullerat, J. Maria
    Castellvi, J.
    Guino, E.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (12) : 2482 - 2488
  • [36] Improved survival in rectal cancer patients who are treated with long-course versus short-course neoadjuvant radiotherapy: A propensity-matched analysis of the NCDB
    Chapman, Brandon C.
    Goodman, Karyn
    Hosokawa, Patrick
    Gleisner, Ana
    Cowan, Michelle L.
    Birnbaum, Elisa
    Vogel, Jon D.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 119 (04) : 518 - 531
  • [37] Preoperative Treatment of Locally Advanced Rectal Cancer: Assets and Drawbacks of Short Course and Long Course in Clinical Practice
    Ngan, Samuel Y.
    SEMINARS IN RADIATION ONCOLOGY, 2016, 26 (03) : 186 - 192
  • [38] Preoperative sequential short-course radiation therapy and FOLFOX chemotherapy versus long-course chemoradiotherapy for locally advanced rectal cancer: a multicenter, randomized controlled trial (SOLAR trial)
    Kang, Min Kyu
    Park, Soo Yeun
    Park, Jun Seok
    Kim, Hye Jin
    Kim, Jong Gwang
    Kang, Byung Woog
    Baek, Jin Ho
    Cho, Seung Hyun
    Seo, An Na
    Kim, Duck-Woo
    Kim, Jin
    Baek, Se Jin
    Kim, Ji Hoon
    Kim, Ji Yeon
    Ha, Gi Won
    Park, Eun Jung
    Park, In Ja
    Kim, Chang Hyun
    Kang, Hyun
    Choi, Gyu-Seog
    BMC CANCER, 2023, 23 (01)
  • [39] Unconsolidated Results of Consolidation Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer Reply
    Tang, Yuan
    Zhou, Hai-Tao
    Li, Ye-Xiong
    Jin, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (34) : 4029 - +
  • [40] Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer
    Pettersson, D.
    Holm, T.
    Iversen, H.
    Blomqvist, L.
    Glimelius, B.
    Martling, A.
    BRITISH JOURNAL OF SURGERY, 2012, 99 (04) : 577 - 583